Medtronic Launches New Diabetes Global Capability Centre in India with $50 Million Investment and Files IPO Prospectus for MiniMed Spin-off

Medtronic Announces Official Launch of New Global Capability Center for Diabetes in India, Plans to Invest $50 Million in India Over Five Years

Medtronic announced on social media: "We are proud to announce the opening of the Global Center for Diabetes Care in India, marking a significant step forward in the transformation of diabetes care. This center exemplifies our unwavering commitment to advancing medical technology and delivering innovative solutions that improve lives."

Medtronic stated that this investment reflects the company's long-term commitment to India's healthcare ecosystem. The center is expected to create 300 jobs in its first year, and its scale will continue to expand in the coming years, enhancing capabilities in patient financial services, digital technology, customer care, and advanced data analytics.

Officially Launched in IndiaBefore the Global Capability Center for Diabetes, Medtronic announcedPlan to split the diabetes business unit. Medtronic believes that the splitThe Diabetes Business Department aims to create "a more focused Medtronic," streamline the business portfolio in high-profit growth markets, and cultivate a leading independent entity in the diabetes sector.

Last week, Medtronic named its newly spun-off company "MiniMed," marking the revival of the brand from the insulin pump business it acquired in 2001 and a return to its roots.MedtronicChoosing MiniMed as the new company name not only carries forward the corporate heritage but also reflects the 40-year historical accumulation in transforming diabetes care.

G